Title : Alanine and terbutaline in the prevention of nocturnal hypoglycemia in IDDM.

Pub. Date : 1997 Aug

PMID : 9250445






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 OBJECTIVE: To test the hypothesis that because of sustained glycemic actions, bedtime administration of the glucagon-releasing amino acid alanine or the epinephrine-simulating beta2-adrenergic agonist terbutaline more effectively prevents nocturnal hypoglycemia than a conventional bedtime snack, we studied 15 patients with IDDM. Terbutaline potassium calcium-activated channel subfamily M regulatory beta subunit 2 Homo sapiens